SBI Securities Co., Ltd.
Broker-DealerPosition in GUTS — Fractyl Health, Inc.
CIK 1851815
TOKYO, M0
Position in GUTS
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$55
-$209 QoQ
Shares Held
121
+0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GUTS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SBI Securities Co., Ltd. holds $11,671,214 across 417 Biotechnology names. GUTS ranks #333 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
39,686 | $1,903,737 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
156,604 | $1,201,152 | |
| 3 | GYRE |
Gyre Therapeutics, Inc.
|
170,837 | $1,190,733 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
31,615 | $1,028,752 | |
| 5 | MRNA |
Moderna, Inc.
|
16,795 | $853,186 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
242,617 | $744,834 | |
| 7 | BNTX |
BioNTech SE
|
6,346 | $564,032 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,237 | $552,369 |
All Filings in GUTS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $55 | 121 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $264 | 120 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $190 | 120 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $194 | 120 | Shares | Defined | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||